Total Funding
31
9
Total FundingPost-IPO Equity raised
Growth Score
-3 pts
Heat Score
-4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
4184988
Phosphagenics is focused on the of new and cost effective ways to enhance the delivery of proven pharmaceutical and nutraceutical products
Harry Rosen: FounderPast Role: Phosphagenics, President
Ross Murdoch: Chief Executive Officer
About the Company
Phosphagenics is focused on the discovery of new and cost effective ways to enhance the delivery of proven pharmaceutical and nutraceutical products.
Phosphagenics’ core technology is built around the science and application of TPM® delivery systems. This unique system enables transdermal delivery of proven pharmaceutical actives and enhances
dermal delivery of pharmaceutical, cosmeceutical and nutraceutical actives. The technology also improves the oral bioavailability of nutritional actives, such as vitamins.
Phosphagenics' shares are listed on the Australian Stock Exchange (POH) and Phosphagenics' ADR's (PPGNY) are traded on the OTCQX in the USA.
